In this FDA inspection webinar attendees will learn the regulatory requirements for all FDA-regulated products. This includes pre-Approval inspection for those products that require a specific submission to FDA, general GMP inspections and for cause inspections, such as those following complaints or recalls. It will also highlight why the prudent firms needs to prepare them self for such inspections.
Why Should You Attend:
All manufacturers of FDA-regulated products, including drugs, foods, cosmetics, medical devices and veterinary products, are subject to the requirements to FDA inspection. This includes pre-Approval inspection for those products that require a specific submission to FDA, general GMP inspections and for cause inspections, such as those following complaints or recalls. The prudent firm will prepare itself for such inspections, using methods such as those to be discussed in this webinar. While this webinar will focus on pharmaceutical requirements, the concepts to be discussed will be applicable to all FDA regulated products.
This webinar will give employees concepts that they can apply to their particular firm in preparing for FDA inspections. It is prudent for all FDA-regulated firms to appoint a group of employees to prepare for FDA inspection. The members of this group require training in how to prepare for an FDA inspection. The consequences of a “failed” FDA inspection (one classified by FDA as OAI) can be quite severe.
Areas Covered in the Webinar:
Who Will Benefit:
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Dr. Loren Gelber has more than 40 years of experience in pharmaceutical industry regulatory compliance. She worked for about 10 years at the FDA, including as a reviewer in the Division of Generic Drugs. She participated in the development of method validation requirements for HPLC analytical methods. She then transitions to industry, working for four different pharmaceutical companies. For the last 13 years she has been a regulatory compliance consultant, both for consulting companies and independently.